Filtros de búsqueda

Lista de obras de

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

scientific article published on 13 February 2019

A study from The Mayo Clinic evaluated long-term outcomes of kidney transplantation in patients with immunoglobulin light chain amyloidosis

artículo científico publicado en 2020

Analysis of Clinical Factors and Outcomes Associated with Non-Utilization of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant Eligible Patients with Multiple Myeloma.

artículo científico publicado en 2018

Autologous Stem Cell Transplant for IgM-Associated Amyloid Light-Chain Amyloidosis

scholarly article by M Hasib Sidiqi et al published March 2019 in Biology of Blood and Marrow Transplantation

Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75

artículo científico publicado en 2018

Autologous stem cell transplantation for multiple myeloma patients aged ≥ 75 treated with novel agents

artículo científico publicado en 2020

Autologous stem cell transplantation in patients with AL amyloidosis with impaired renal function

scientific article published on 08 April 2019

Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia

artículo científico publicado en 2018

Blood mass spectrometry detects residual disease better than standard techniques in light-chain amyloidosis

artículo científico publicado en 2020

Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

scientific article published on 22 November 2019

Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma

scholarly article by M Hasib Sidiqi et al published 8 November 2018 in Blood Cancer Journal

Characteristics of exceptional responders to autologous stem cell transplantation in multiple myeloma

scientific article published on 28 August 2020

Characteristics of long-term survivors with multiple myeloma: A National Cancer Data Base analysis

artículo científico publicado en 2019

Characterization and prognostic implication of delayed complete response in AL amyloidosis

scientific article published on 23 November 2020

Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities

artículo científico publicado en 2020

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis

scientific article published on 05 March 2019

Colon perforation in multiple myeloma patients - A complication of high-dose steroid treatment

scientific article published on 06 October 2020

Comparative analysis of staging systems in AL amyloidosis

scientific article published on 23 January 2019

Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis

Correction: Bone marrow plasma cells 20% or greater discriminate presentation, response, and survival in AL amyloidosis

artículo científico publicado en 2020

Correlation between urine ACR and 24-h proteinuria in a real-world cohort of systemic AL amyloidosis patients

artículo científico publicado en 2020

Cytogenetic Features and Clinical Outcomes of Patients With Non-secretory Multiple Myeloma in the Era of Novel Agent Induction Therapy

artículo científico publicado en 2019

Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response

artículo científico publicado en 2020

Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis

artículo científico publicado en 2018

Delayed neutrophil engraftment in patients receiving Daratumumab as part of their first induction regimen for multiple myeloma

scientific article published on 21 October 2019

Delineation of the timing of second line therapy post- autologous stem cell transplant in patients with AL amyloidosis

artículo científico

Depth of organ response in AL amyloidosis is associated with improved survival: grading the organ response criteria.

artículo científico publicado en 2018

Depth of organ response in AL amyloidosis is associated with improved survival: new proposed organ response criteria

scientific article published on 01 January 2019

Depth of response prior to autologous stem cell transplantation predicts survival in light chain amyloidosis

artículo científico publicado en 2020

Development of thrombocytopenia during first-line treatment and survival outcomes in newly diagnosed multiple myeloma

artículo científico publicado en 2019

Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia

artículo científico

Differences in engraftment with day-1 compared with day-2 melphalan prior to stem cell infusion in myeloma patients receiving autologous stem cell transplant

artículo científico publicado en 2020

Efficacy of VDT PACE-like regimens in treatment of relapsed/refractory multiple myeloma

artículo científico publicado en 2017

Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials

artículo científico publicado en 2017

Elevation of serum lactate dehydrogenase in AL amyloidosis reflects tissue damage and is an adverse prognostic marker in patients not eligible for stem cell transplantation

artículo científico publicado en 2017

Enhancing the R-ISS classification of newly diagnosed multiple myeloma by quantifying circulating clonal plasma cells

artículo científico publicado en 2020

Fifteen year overall survival rates after autologous stem cell transplantation for AL amyloidosis

scientific article published on 11 July 2019

Hematology patient reported symptom screen to assess quality of life for AL amyloidosis

artículo científico publicado en 2017

Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patients

scientific article published on 29 October 2019

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes

scientific article published on 29 August 2019

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

scientific article published on 31 December 2019

Impact of acquired del(17p) in multiple myeloma

artículo científico publicado en 2019

Impact of consolidation therapy post autologous stem cell transplant in patients with light chain amyloidosis

scientific article published on 23 July 2019

Impact of duration of induction therapy on survival in newly diagnosed multiple myeloma patients undergoing upfront autologous stem cell transplantation.

artículo científico publicado en 2018

Impact of minimal residual negativity using next generation flow cytometry on outcomes in light chain amyloidosis

artículo científico publicado en 2020

Impact of prior diagnosis of monoclonal gammopathy on outcomes in newly diagnosed multiple myeloma

scientific article published on 20 February 2019

Implications and outcomes of MRD-negative multiple myeloma patients with immunofixation positivity

scientific article published on 30 December 2019

Implications of MYC Rearrangements in Newly Diagnosed Multiple Myeloma

artículo científico publicado en 2020

Implications of detecting serum monoclonal protein by MASS-fix following stem cell transplantation in multiple myeloma

artículo científico publicado en 2020

Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death

artículo científico publicado en 2017

Increased Bone Marrow Plasma-Cell Percentage Predicts Outcomes in Newly Diagnosed Multiple Myeloma Patients

scientific article published on 07 April 2020

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

artículo científico publicado en 2018

Long-term outcomes of IMiD-based trials in patients with immunoglobulin light-chain amyloidosis: a pooled analysis

artículo científico publicado en 2020

Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma

artículo científico publicado en 2020

Monoclonal gammopathy plus positive amyloid biopsy does not always equal AL amyloidosis

artículo científico publicado en 2019

Multicentric Castleman disease – a single center experience of treatment with a focus on autologous stem cell transplantation

Natural history of multiple myeloma with de novo del(17p)

scholarly article by Arjun Lakshman et al published 7 March 2019 in Blood Cancer Journal

Optimizing deep response assessment for AL amyloidosis using involved free light chain level at end of therapy: failure of the serum free light chain ratio

scientific article published on 26 September 2018

Outcomes and treatments of patients with immunoglobulin light chain amyloidosis who progress or relapse postautologous stem cell transplant.

artículo científico publicado en 2014

Outcomes of Multiple Myeloma Patients with Del 17p Undergoing Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Outcomes of Patients with Light Chain Amyloidosis Who Had Autologous Stem Cell Transplantation with 3 or More Organs Involved

artículo científico publicado en 2019

Outcomes with different administration schedules of Bortezomib in Bortezomib, Lenalidomide and dexamethasone (VRd) as first-line therapy in Multiple Myeloma

scientific article published on 16 December 2020

Outcomes with early response to first-line treatment in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2019

Overall survival of transplant eligible patients with newly diagnosed multiple myeloma: comparative effectiveness analysis of modern induction regimens on outcome

scholarly article by Ashley R Paquin et al published 11 December 2018 in Blood Cancer Journal

Overuse of organ biopsies in immunoglobulin light chain amyloidosis (AL): the consequence of failure of early recognition

artículo científico publicado en 2017

Peripheral blood biomarkers of early immune reconstitution in newly diagnosed multiple myeloma

scientific article published on 13 December 2018

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

article published in 2018

Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response

artículo científico publicado en 2018

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation.

artículo científico publicado en 2018

Predictors of short-term survival in Waldenström Macroglobulinemia

artículo científico publicado en 2020

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

artículo científico publicado en 2017

Prognostic Role of Beta-2 Microglobulin in Patients with Light Chain Amyloidosis Treated with Autologous Stem Cell Transplantation

artículo científico publicado en 2020

Prognostic Significance of Holter Monitor Findings in Patients With Light Chain Amyloidosis

scientific article published on 02 February 2019

Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis

artículo científico publicado en 2018

Prognostic restaging at the time of second-line therapy in patients with AL amyloidosis

artículo científico publicado en 2019

Prognostic significance of circulating plasma cells by multi-parametric flow cytometry in light chain amyloidosis.

artículo científico publicado en 2018

Prognostic significance of interphase FISH in monoclonal gammopathy of undetermined significance

scientific article published on 30 January 2018

Prognostic value of NT-ProBNP and troponin T in patients with light chain amyloidosis and kidney dysfunction undergoing autologous stem cell transplantation

artículo científico publicado en 2020

Prognostic value of minimal residual disease and polyclonal plasma cells in myeloma patients achieving a complete response to therapy

artículo científico publicado en 2019

Refining amyloid complete hematological response: quantitative serum free light chains superior to ratio

artículo científico publicado en 2020

Relapse after complete response in newly diagnosed multiple myeloma: implications of duration of response and patterns of relapse

artículo científico publicado en 2018

Retroperitoneal involvement with light chain amyloidosis- case series and literature review

artículo científico publicado en 2020

Revisiting complete response in light chain amyloidosis

scientific article published on 26 November 2019

Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

artículo científico publicado en 2018

Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation

artículo científico publicado en 2018

Serum free light chain measurements to reduce 24-h urine monitoring in patients with multiple myeloma with measurable urine monoclonal protein

scientific article published on 15 August 2018

Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time.

artículo científico publicado en 2018

Survival impact of achieving minimal residual negativity by multi-parametric flow cytometry in AL amyloidosis

scientific article published on 23 September 2019

Ten-year survivors in AL amyloidosis: characteristics and treatment pattern

scientific article published on 12 July 2019

The prognostic significance of polyclonal bone marrow plasma cells in patients with relapsing multiple myeloma

artículo científico publicado en 2017

The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?

scientific article published on 06 May 2020

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

artículo científico publicado en 2017

Time to plateau as a predictor of survival in newly diagnosed multiple myeloma.

artículo científico publicado en 2018

Trends and outcomes of modern staging of solitary plasmacytoma of bone

artículo científico publicado en 2012

Two types of amyloidosis presenting in a single patient: a case series

artículo científico publicado en 2019

Use of Beta Blockers is Associated with Survival Outcome of Multiple Myeloma Patients Treated with Pomalidomide

artículo científico publicado en 2020

Utility and prognostic value of 18 F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

artículo científico publicado en 2018

Utility of repeating bone marrow biopsy for confirmation of complete response in multiple myeloma

artículo científico publicado en 2020

Utility of serum free light chain ratio in response definition in patients with multiple myeloma

artículo científico publicado en 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

artículo científico publicado en 2019

Utilizing multiparametric flow cytometry in the diagnosis of patients with primary plasma cell leukemia

artículo científico publicado en 2020

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

scientific article published on 11 May 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda